Alexander Statement on the Nomination of Dr. Stephen Hahn to Serve as FDA Commissioner

KNOXVILLE, Tenn., November 1, 2019 – U.S. Senate health committee Chairman Lamar Alexander (R-Tenn.) today made the following statement on the selection of Dr. Stephen Hahn to lead the Food and Drug Administration (FDA): 

“Having the right person lead the FDA is critical to virtually every American. The FDA is responsible for ensuring drugs and medical devices that patients rely on are safe and effective, protecting the nation’s food supply, regulating tobacco products, and implementing 21st Century Cures and new federal laws to help combat the opioid crisis. I look forward to meeting with Dr. Hahn and scheduling a hearing to consider his nomination.”  

Dr. Hahn currently serves as the chief medical executive at the University of Texas MD Anderson Cancer Center in Houston.